Cargando…
Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086170/ https://www.ncbi.nlm.nih.gov/pubmed/33676614 http://dx.doi.org/10.1016/S0140-6736(21)00528-6 |
| _version_ | 1783686472629485568 |
|---|---|
| author | Hung, Ivan F N Poland, Gregory A |
| author_facet | Hung, Ivan F N Poland, Gregory A |
| author_sort | Hung, Ivan F N |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8086170 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80861702021-05-03 Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster Hung, Ivan F N Poland, Gregory A Lancet Comment Elsevier Ltd. 2021 2021-03-04 /pmc/articles/PMC8086170/ /pubmed/33676614 http://dx.doi.org/10.1016/S0140-6736(21)00528-6 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Hung, Ivan F N Poland, Gregory A Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster |
| title | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster |
| title_full | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster |
| title_fullStr | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster |
| title_full_unstemmed | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster |
| title_short | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster |
| title_sort | single-dose oxford–astrazeneca covid-19 vaccine followed by a 12-week booster |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086170/ https://www.ncbi.nlm.nih.gov/pubmed/33676614 http://dx.doi.org/10.1016/S0140-6736(21)00528-6 |
| work_keys_str_mv | AT hungivanfn singledoseoxfordastrazenecacovid19vaccinefollowedbya12weekbooster AT polandgregorya singledoseoxfordastrazenecacovid19vaccinefollowedbya12weekbooster |